October 23-27, 2026 | Madrid
ESMO 2026
ESMO is the largest European meeting in medical oncology, covering the full breadth of oncology drug development.
Peregrion attends to discuss AMS microtracer applications for oncology compounds, including bioavailability, mass balance, and metabolite work.
Activities
1:1 sponsor meetings around the congress.
Attending from Peregrion
- Suzanne van Gerwen (VP Business Development)
Topics for discussion
- AMS microtracer studies for oncology compounds
- MIST package generation from Phase 1
- Mass balance and absolute bioavailability for oncology assets
- Compounds presenting radiolabel synthesis challenges
- Case examples from oncology projects
Book a meeting with our team: info@peregrion.com.
